Patent details
301317 Product Name: Combinatie van epinefrine of een zout daarvan, en dodecylmaltoside
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
- Publication number:
- 301317
- Type:
- Certificate
- SPC Type:
- Medical
- Basic Patent Number:
- EP3678649
- Status:
- Application Pending
- Application number:
- 301317
- Procedural language:
- Dutch
- First Applicant Residence Country:
- United States of America (US)
Marketing Authorization
- Marketing Authorization Number:
- EU1/24/1846
- Marketing Authorization Type:
- EEA
- Marketing Authorization Date:
- 23/08/2024
- Marketing Authorization Country:
- European Union (EU)
Dates
- Filing date:
- 11/02/2025
- First Marketing Authorization date:
- 23/08/2024
- Grant date:
- Activation date:
- Lapsed By Non Payment Annual Fee Date:
- Renunciation Date:
- NullificationDate:
- Registration date:
- 11/02/2025
- SPC/SPC Extension Expiration Date:
- Lapsed By Expiration Date:
- Withdrawal date:
- Revocation Date:
- Invalidity Date:
- Withdrawal Market Authorization Date:
- Refusal Date:
Applicant/holder
- From:
- 11/02/2025
- Name:
- Aegis Therapeutics, LLC
- Address:
- 3430 Carmel Mountain Road, Suite 300, 92121, San Diego, CA , United States of America (US)
- From:
- 11/02/2025
- Name:
- ARS Pharmaceuticals Operations, Inc.
- Address:
- 11682 El Camino Real, Suite 120, 92130, San Diego, California, United States of America (US)
Agent
- Name:
- ir. F.A. Geurts c.s.
- From:
- 11/02/2025
- Address:
- Octrooibureau Vriesendorp & Gaade B.V. Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
- To:
Publication
Bulletin
- Bulletin Heading:
- SPC
- Journal edition number:
- 07/25
- Publication date:
- 12/02/2025
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
| Filing date | Document type | Document Description | Number of pages | File Type | ||
|---|---|---|---|---|---|---|
| 11/02/2025 | SPC Documents | Annex SPC | 165 | /9/6/1/4/8/0801084169/docs/301317_0_supplprotectioncertificate20250211120537864.pdf | ||
| 11/02/2025 | SPC Documents | Marketing Authorization SPC | 3 | /9/6/1/4/8/0801084169/docs/301317_1_supplprotectioncertificate20250211120722019.pdf | ||
| 11/02/2025 | SPC Documents | Annex SPC | 2 | /9/6/1/4/8/0801084169/docs/301317_2_supplprotectioncertificate20250211120808615.pdf | ||
| 11/02/2025 | SPC Documents | Summary of the characteristics of the product | 16 | /9/6/1/4/8/0801084169/docs/301317_3_supplprotectioncertificate20250211120702481.pdf | ||
| 11/02/2025 | SPC Documents | Accompanying letter SPC | 13 | /9/6/1/4/8/0801084169/docs/301317_4_supplprotectioncertificate20250211120557563.pdf | ||
| 11/02/2025 | Outgoing Correspondence | Confirmation receipt request | 2 | /9/6/1/4/8/0801084169/docs/301317_5_643438l174.pdf | ||
| 11/02/2025 | Application Form | First filed application form | 4 | /9/6/1/4/8/0801084169/docs/301317_6_applicationform20250211120301914.pdf | ||
| 11/02/2025 | SPC Documents | Annex SPC | 1 | /9/6/1/4/8/0801084169/docs/301317_7_supplprotectioncertificate20250211120455970.pdf | ||
| 11/02/2025 | SPC Documents | Annex SPC | 5 | /9/6/1/4/8/0801084169/docs/301317_8_supplprotectioncertificate20250211120355443.pdf |